Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer.

Name: Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer.
Author: Aguiar, Pedro Nazareth

Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer. — المؤلف: Aguiar, Pedro Nazareth — Einstein (Sao Paulo, Brazil) 20190318

المؤلف: Aguiar, Pedro Nazareth
النشر: Einstein (Sao Paulo, Brazil) 20190318
الوصف: eGS4414 p.
الموضوعات: Androgen Antagonists؛ Androstenes؛ Antineoplastic Agents, Hormonal؛ Antineoplastic Combined Chemotherapy Protocols؛ Brazil؛ Cost-Benefit Analysis؛ Docetaxel؛ Humans